Member Info for comek2

“… and highlighted that Big Pharma don’t really have AI at the forefront of their operational systems and set up, so maybe there is an opportunity here for a tie up once we know the Utility of CapMed.“

Will Dr Nag’s CPAI develop AI apps for the pharma industry and sell to them, like he did with Apple, Blackberry and Motorola? He has stated before to keep competition at bay he intended to use complex deep-tech. Therefore even big pharma while they have the financial muscle they may not have Dr Nag’s AI expertise, or quickly enough, and would thus be in need of his apps, or/and partnership. In the presentation on the link posted by dpend earlier he also highlights Dior and Laura Ester interests in longevity AI, as well as the Wellness & Lifestyle sector. He seems to sets his eyes on a wider markets which bodes well for CPAI. We only need to be successful in one of these sectors for CPAI to be established as a serious company for other companies and other sectors to come knocking at our door.

From the link posted by dpend (thanks btw), in the presentation page 13 on the YouTube image the caption says “Our next big predictions: the rise of the hyper-unicorn- companies hitting $1B+ valuation in under 6 months.”

I've always said I'd expect CPAI share price to reach 50p-£1 in 1-2 years time. This looks conservative comparatively in light of dr Nag “6 months” timeframe. In R42 we have over 100 companies. If only 10% are successful, CPAI should be a multi billions company in a relatively short time- let’s remember given his achievements so far, there is nothing else for dr Nag to achieve but to make of CPAI a British equivalent of one of those U.S. Silicon Valley companies.

Great interview and last 2 rns, thanks Filterland. Being under the radar is a blessing in disguise. Accumulate at this low price before the herd eventually come following tangible progress. I have no doubt Dr Ron wants to make CPAI a British equivalent of one of those Silicon Valley company one wished they invested in in their infancy. What else is there for Dr Ron to achieve, given his pedigree?

Didn’t Amroq say they’re talking to the U.S. government for possible investment in the company. And the now the Japanese government.

Https://www.cnbc.com/amp/2026/02/03/rare-earths-stocks-trump-critical-minerals-stockpile-project-vault.html

Alboumphoto, is it a coincidence you and the other idiot Elmagico stopped posting the day Dr Nag was mentioned in the House of Commons? Go and seek credibility elsewhere, you’ve lost it here and no one was taking you seriously anyway. Or stay and carry on being the village idiot.

“Yea I did the same thing at 0.9, 1,1.1 etc thinking bargain, I’ll average down“. Averaging down is the name of the game with the small cap. And you’re doing it at a good price, not far off where the sp is atm. So why are you complaining?

As to “we’ll need 200%” to get to pre consolidation level. The sp did 6000% up in 3 months following dr Nag involvement with CPAI. Why can’t it do the same or even more when we have 100 cos to draw from, some with revolutionary techs?

Giancotti: “If Dr N decided tomorrow to pull out and focus on other projects this would be worthless.“

The above applies to any company on the stock market, particularly the small cap. By your logic, you shouldn’t be investing in this section of the stock market. What don’t you understand by “ small cap is a high risk high reward investment.”? You’re either a novice, or have an agenda.

What some people seem to miss is the fact that with R42 having 100 cos, even if some companies fail there are plenty that will be successful to be incubated within CPAI since dr Nag says it himself and worth repeating: “I am totally committed to developing capAI into a major player in the AI space, using my own innovations as well as R42 Group resources“. Having invented 4 top techs for smart devices, who in the world would think dr Nag will fail in all his 100 cos?

Thank for the reminder koolkat15: “I am totally committed to developing capAI into a major player in the AI space, using my own innovations as well as R42 Group resources“

This statement alone from Dr Nag is enough to reassure investors, unless some want to be seen as idiots spreading doom and gloom for lack of research, or personal agenda . R42 has over 100 cos, some with very promising revolutionary technologies which, as dr Nag seems to be suggesting, will feed CPAI nonstop. If just 2 or 3 are successful which statistically is a given (2/3%) and with dr Nag’s expertise, the sp will motor to no less than 10p.

This is a start up company of less than a year old and the sp behaviour is normal for such companies. The hype initially takes the sp unrealistically too high and with time it falls down to a level reflecting the natural slow progress of such start up until one of the milestones materialises. Therefore thrre is no objective reasons for doom and gloom. Go to the FTSE for 5-10% sp increase yearly. The small cap is very volatile, and it’s a high risk but high reward too. Patience is needed, as no pain no gain.

I’ve topped up 111805 for £1012 and will continue to take advantage of such low price whenever funds are available.

ElMagico, you didn’t know Dr Ron’s R42 had over 100 companies and as such he was busy with them, before you invested in CPAI? DYOR comes to mind….or farting.

You think with his pedigree, and how busy he’s with all his ventures, teaching etc…, he would waste his time with CPAI for which he’s not even paid let alone put in £50k of his own money. Add his companies he has handed over for free to CPAI, and more as progress is made. This last point makes me believe he has a plan for CPAI to make it the TESLA of the AI revolution. I say this because having achieved so much, what else is there to achieve for himself other than making of a start up a unicorn company? In fact his projects with AI and indeed for CPAI is to enable entrepreneurs to build companies of $billionn+, he actually used the word “unicorn” companies run by “one or 2 people”. If he aims to do this for others what he plans to do for his, ie CPAI in our case, having 100 cos to feed it?

As to him and other BOD members being busy with other companies. Are you a novice investor or pretending to be to suit your too obvious silly agenda? A) They’re not paid a salary but their remunerations is aligned with shareholders, which is very rare in the stock market particularly the small cap. B) being a BOD in various companies is actually the norm in the stock market including the FTSE, but more so in AIM and the small cap, and for obvious reasons ie wider experience and expertise.

As to the sp, well it’s disappointing but AGAIN that’s the nature of small cap especially a start up, over 90% are down 70-90% over the last year. Small companies take at least 3-5 years to show progress, and CPAI is only 9 months old and has made tremendous progress so far. However we are in a fast moving technological sector so I’d expect this year to be well rewarding sp wise, but I have given myself 2-3 years to be a millionaire hopefully.

If you want to have the acolyte of the smartest idiot on this bb, well carry on with your line of thinking, aided with 1 or 2 alike turned traders. Some people get cross-wiring of their brain & bum from birth (so not their fault really), and in some accents brain and bum sound similar, at least phonetically. So fart all you want the sp won’t react accordingly.

Sorry, here is the link:

https://www.linkedin.com/posts/oxforddrugdesign_crowdfunding-ai-drugdiscovery-activity-7414320299799883776-owJt?utm_source=share&utm_medium=member_ios&rcm=ACoAAA2uNNwBoQ-5IwwwBKIC0zEhck3tCZ0MZ_c

Another one from Ronjon Nag on LinkedIn again today,

“A great opportunity to look at one of our AI drug discovery companies pushing the boundaries of cancer treatment “,

Oxford Drug Design

Join the 200+ investors already registered and get exclusive priority access to our Republic Europe crowdfunding campaign! 🚀 

 

If you’d like the chance to buy equity in our business and join us in our mission to develop novel medicines using cutting-edge AI, register now for exclusive early access to our crowdfunding campaign 👉 https://lnkd.in/eQeg3nYG 

 

Be part of our future and take the opportunity to support advances in innovative medicines against cancer and other serious diseases, such as drug-resistant infections faster and with superior AI-precision. 

 

Having already achieved successful animal proof-of-concept for a potential breakthrough approach targeting around 70% of tumours - in partnership with leading Cancer Research UK (CRUK) collaborators - our science has already attracted £10m in international grants and equity investments. 

 

Don’t invest unless you’re prepared to lose all the money you invest.

Approved by Republic Europe on 24/11/2025. 

 

#crowdfunding #AI #drugdiscovery #investment #cancerresearch

Interesting posts From Dr Nag today, also mentioning CPAI:

AI Insiders: Healthcare & Biotech · Luma | Ronjon Nag

“Talking next JP Morgan week at AI Insiders about companies I am driving that are accelerating AI in Life Sciences - Superbio.ai (vibecoding for life sciences), Agemica.ai (aging and cancer vaccines), Ikshana (curing Dry AMD), R42 Group (AI and Longevity Science Funds), CapAI (AI for medical). If anybody wants an appointment with me, DM me or see me at AI Insiders https://luma.com/aihealth ! Anastasiya K. Giarletta Seifollahi zixuan an R42 Group Superbio.ai AGEMICA Merve Isler Anna Lindfors”

https://www.linkedin.com/posts/ronjonnag_ai-insiders-healthcare-biotech-luma-activity-7414939326431584256-WC59?utm_source=share&utm_medium=member_ios&rcm=ACoAAA2uNNwBoQ-5IwwwBKIC0zEhck3tCZ0MZ_c

Dr Ron also introduces his lead manager of Melio, one of his R42 companies, Mridu Sinha. Melio detects 50 pathogens at the same time.

Mridu Sinha says “At Melio, we are proud of the progress we have made to deliver a rapid, direct-from-blood microbial testing platform designed to deliver actionable results in hours, not days, without culture, targeted probes, or sequencing.”

With with the 100 companies under Dr Ron’s management and expertise, I remain more than convinced only 2 or 3 successful companies which I have not doubt will statistically 100% happen, will make many retire handsomely very early…..but a little too late for me lol.

I like the title of the conference which suggests progress is being made.

“WHAT'S ACTUALLY WORKING IN AI FOR HEALTH & BIOTECH

IN 2026. (and what's still fantasy)”

And more interestingly the last part of the sentence, the post goes on to say “Join us in person to meet him and hear what he’s working on next, before it’s publicly announced.”

ContrarianQuest, you ironically subsequently confirmed you’re a trader and as such looking for a cheap entry or shorting. Otherwise why are you concerned with “short-term price behaviour ….stock trading into unknown supply.”?

“ short-term price behaviour The point being made is purely about short-term price behaviour when a stock is already trading into known supply.” And also that you’re a muppet, denying that which you confirm lol.

ContrarianQuest, are you looking for cheap entry. Or are you short, muppet?

ElMagico: “progress being made by organisations that have absolutely nothing to do with us, so how does that bode well for us”

You’ve just confirmed that you’re not an investor, but a trader ie a gambler.

Any progress made by any company in the same field will have a positive impact on the rest. Cause it validates the claim made by the others ie CPAI anti-aging/longevity targeting.

Good luck with your gambling, ie trading, and if you know of any successful gambler in history I’d like to know their name. My last to post to you to keep the bb free from your drivel, and to not waste my time.

ElMagico, if you were a real investor you wouldn’t ask such question. From the man himself:

“Looking forward today to presenting “Using AI to find a Vaccine for Aging” at the Unicorn Summit in Lisbon, showcasing CapAI, R42, Agemica and Superbio.AI, all making their way to unicorn status ! https://unicornsummit.net”

https://www.linkedin.com/feed/update/urn:li:activity:7345018597645176832